Skip to content

Network Pharmacology and Experimental Validation of the Ameliorative Effect of Rosa rugosa Essential Oil on Scopolamine‐Induced Cognitive Dysfunction in Mice

Sep 2026 · Flavour and Fragrance Journal · 0 citations · 38 references

TL;DR

Animal experiments demonstrated that RrEO improved cognitive behaviour in mice, reduced central cholinergic neuronal damage and oxidative stress in the brain, increased the levels of monoamine neurotransmitters dopamine and 5‐hydroxytryptamine (5‐HT), preserved neuronal cell structure, and decreased cell apoptosis.

Abstract

In this study, common targets of Alzheimer's disease (AD) and the main components of Rosa rugosa essential oil (RrEO) were collected from databases including GeneCards, PubChem and STRING. Protein–protein interaction (PPI) networks were constructed, followed by GO functional enrichment analysis and KEGG pathway enrichment analysis using DAVID and Metascape databases. The enrichment results were further validated in a scopolamine (SCO)‐induced cognitive impairment mouse model through olfactory inhalation administration of RrEO. Network pharmacology analysis revealed 201 potential therapeutic targets of RrEO, among which AKT1, TNF, and BCL2 were identified as core targets, closely associated with oxidative stress, neuronal and lipid metabolism, brain neurotransmitter systems, and cytoprotection. Animal experiments demonstrated that RrEO improved cognitive behaviour in mice, reduced central cholinergic neuronal damage and oxidative stress in the brain, increased the levels of monoamine neurotransmitters dopamine and 5‐hydroxytryptamine (5‐HT), preserved neuronal cell structure, and decreased cell apoptosis. These experimental findings further corroborated the results obtained from the network pharmacology analysis of RrEO.

View source

Similar papers

Open access Sep 2026

Combined metabolomics and network pharmacology explore the protective mechanism of bornyl acetate against cognitive impairment in chronic sleep-deprived mice

Chronic sleep deprivation (CSD) is currently a serious global public health concern, and CSD induces numerous diseases, including cognitive impairment. Bornyl acetate (BA) possesses a brilliant anti-inflammatory activity and plays a favorable role in neuroinflammation. The purpose of this research was to explore the ef...

Qing Lv, Mei-Ya Zhang, Rui-Ling Sun et al. · 0 citations
Sep 2026

Deciphering the Molecular Mechanisms of Apigenin in Neurodegenerative Diseases Through Network Pharmacology, Molecular Docking, and DFT Analysis

Its favorable binding characteristics, electronic stability, and predicted brain permeability highlight apigenin as a potential candidate for the prevention and treatment of neurodegenerative diseases, warranting further experimental and clinical validation.

Anish Singh, Diksha Dalal, Lovedeep Singh · 0 citations
Sep 2026

Betulin supplementation reduces oxidative stress in Alzheimer's disease via the activation of KEAP1/NRF2 pathway.

Betulin (BE) is extracted from pentacyclic triterpenoids of many natural plants and has antioxidation activities. However, the neuroprotective effects and underlying mechanism of Betulin in Alzheimer's disease (AD) have remained limited. Integrate SuperPred, SEA, and Targeted Net databases, as well as KEGG pathway enri...

Cong-Hui Dai, Yao Yang, Xia-Oou Lin et al. · 0 citations
Open access Sep 2026

Investigating the Pharmacological Basis of Xiaochaihu-Tang in Diabetic Cognitive Impairment: A Network Pharmacology Approach

Background/Objectives: Diabetic Cognitive Impairment (DCI) involves cognitive impairment resulting from diabetes-triggered metabolic abnormalities and neuroinflammation; however, the therapeutic mechanisms of Xiaochaihu-tang (XCHT) remain unclear. Methods: This study systematically explored the potential pharmacologica...

B. Joo, Dong-Uk Kim, Bitna Kweon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.